CBRNE - Ricin Treatment & Management

  • Author: Ferdinando L Mirarchi; Chief Editor: Robert G Darling, MD, FACEP   more...
 
Updated: Jun 7, 2010
 

Prehospital Care

Strictly adhere to universal precautions at all times, although secondary dermal absorption to prehospital providers is not expected. The risk of secondary aerosolization is minimal. Use protective masks, which are effective in preventing toxicity, when an overt aerosol attack is suspected.

Next

Emergency Department Care

  • Management
    • ED management begins with universal precautions and the ABCs. Add a "D" for decontamination (including the removal of garments). If ingestion is possible, based on the history and presenting findings, consider gut decontamination as well.
    • Management also involves the ability to recognize, diagnose, and treat a possible biological event.
  • Decontamination
    • Decontamination begins by removing garments and cleaning with soap and water.
    • If available, use a 0.5% sodium hypochlorite solution with a contact time of 15 minutes. Do not instill this solution into open abdominal, brain, or spinal cord injuries or into the eyes. It can be instilled into noncavity wounds and then removed via suction into disposable containers. This discarded solution is neutralized and nonhazardous in 5 minutes. To make a 0.5% sodium hypochlorite solution, mix 1 part bleach and 9 parts water. Make it fresh daily with a pH in the alkaline range. In the absence of this solution, copious amounts of soap and water may be used.
  • Diagnosis
    • Diagnosis of an aerosolized attack or food and water contaminant with ricin is similar to that of any of the biological or chemical agents that serve as WMDs. It primarily depends on the clinical and epidemiologic setting. In cases of isolated injection, the diagnosis is extremely difficult.
    • The clinical presentation of acute lung injury in a large number of patients in a particular area should suggest a pulmonary irritant. The clinical presentation of severe gastroenteritis or hemorrhagic gastroenteritis in a large number of patients in a particular area should suggest a food and water contaminant.
    • Include ricin and other agents (eg, staphylococcal enterotoxin B, Q fever, tularemia, pneumonic plague, inhalational anthrax, chemical agents such as phosgene) in the differential diagnosis.
    • Ricin is expected to progress despite antibiotic therapy. Chest radiograph exhibits no evidence of mediastinitis, as would be expected with pulmonary anthrax.
    • Staphylococcal enterotoxin B does not progress to a life-threatening syndrome, and phosgene produces ARDS, which is mediated by exertion. Phosgene also has the characteristic odor of newly mown hay or grass and is quite irritating to mucous membranes in lethal amounts.
  • Diagnostic testing: Diagnostic testing is of limited value (see Workup).
  • Treatment
    • Treatment and toxicity depend on the route of exposure. Treatment is supportive, and no antidote is available for ricin.
    • Emergency department employees should obey strict universal precautions at all times.
    • For dermal exposure, a weak sodium hypochlorite solution (0.1%) and/or soap and water suffice to decontaminate the skin.
    • For GI exposure, include gastric decontamination with superactivated charcoal, volume replacement, and H2 blockers in treatment. Include chemistry panels, complete blood count, liver function panel, BUN and creatinine, urinalysis, and type and screen in the laboratory evaluation.
    • For percutaneous exposure, base treatment on excision of the injection site, if possible, within the shortest amount of time. Obtain baseline laboratory information, including arterial blood gas and fibrinogen. Although antibiotics serve no role in the treatment of ricin, withholding such therapy in an acutely septic-appearing patient would be difficult. Antibiotics may serve to prevent infection resulting from the percutaneous mechanism. Update tetanus immunization status if unknown.
    • For aerosol or pulmonary exposure, provide standard critical care treatment directed toward acute lung injury and pulmonary edema. Maintain a low threshold to secure the patient's airway and ensure adequate oxygenation and ventilation. Obtain a chest radiograph, which may show infiltrates. The clinical course progresses despite antibiotic therapy.
    • The only effective treatment for ricin toxicity is prevention. Current investigations are underway with candidate vaccines and ricin inhibitors as antidotes or to facilitate immunotoxin treatment. Pteroic acid, neopterin, pterin tautomer, and guanine tautomer are particularly useful. To date, small human trials have been conducted and are promising; however, vaccine trials still require additional testing for safety and efficacy.
  • Disposition: Admit and monitor any symptomatic patient and perform aggressive volume resuscitation.
Previous
Next

Consultations

Surgical consultation for local excision and removal is warranted for parenteral exposures when a retained foreign body is located.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Ferdinando L Mirarchi  DO, Medical Director and Director of Operations, Department of Emergency Medicine, UPMC-Hamot, Academic Core Faculty for Hamot Medical Center, Emergency Medicine Residency Program, Lake Erie College of Osteopathic Medicine

Ferdinando L Mirarchi is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Osteopathic Emergency Physicians, and Emergency Medicine Residents Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Jerry L Mothershead, MD  Medical Readiness Consultant, Medical Readiness and Response Group, Battelle Memorial Institute; Advisor, Technical Advisory Committee, Emergency Management Strategic Healthcare Group, Veteran's Health Administration; Adjunct Associate Professor, Department of Military and Emergency Medicine, Uniformed Services University of the Health Sciences

Jerry L Mothershead, MD is a member of the following medical societies: American College of Emergency Physicians and National Association of EMS Physicians

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Robert G Darling, MD, FACEP  Adjunct Clinical Assistant Professor of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, F Edward Hebert School of Medicine; Associate Director, Center for Disaster and Humanitarian Assistance Medicine

Robert G Darling, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, American Telemedicine Association, and Association of Military Surgeons of the US

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, Michael P Allswede, DO, to the development and writing of this article.

References
  1. CDC and Public Health Training Network. Recognition, Management and Surveillance of Ricin-Associated Illness [Web cast script]. December 30, 2003. [Full Text].

  2. CNN.com. Timeline: UK ricin terror probe. January 23, 2003. [Full Text].

  3. Balint GA. Ricin: the toxic protein of castor oil seeds. Toxicology. Mar 1974;2(1):77-102. [Medline].

  4. Challoner KR, McCarron MM. Castor bean intoxication. Ann Emerg Med. Oct 1990;19(10):1177-83. [Medline].

  5. Ellenhorn MJ, Barceloux DG. Ornamental beans. In: Medical Toxicology Diagnosis and Treatment of Human Poisoning. 1988:1225-27.

  6. FBI. Federal Bureau of Investigations Web Page. Available at www.fbi.gov. Accessed 2000.

  7. Franz D, USAMRIID. Defense against toxic weapons. In: US Army Medical Research Material Command. 1997.

  8. Kopferschmitt J, Flesch F, Lugnier A, et al. Acute voluntary intoxication by ricin. Hum Toxicol. Apr 1983;2(2):239-42. [Medline].

  9. Kortepeter MG, Parker GW. Potential biological weapons threats. Emerg Infect Dis. Jul-Aug 1999;5(4):523-7. [Medline].

  10. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science. Nov 18 1994;266(5188):1202-8. [Medline].

  11. Shih RD, Goldfrank LR. Plants. In: Goldfrank's Toxicologic Emergencies. 6th ed. 1998:1254-55.

  12. US Medical Research Institute of Infectious Diseases. Medical Management of Biocasualities Handbook. 1998.

  13. Zilinskas RA. Iraq's biological weapons. The past as future?. JAMA. Aug 6 1997;278(5):418-24. [Medline].

Previous
Next
 
Chemical Terrorism Agents and Syndromes. Signs and symptoms. Chart courtesy of North Carolina Statewide Program for Infection Control and Epidemiology (SPICE), copyright University of North Carolina at Chapel Hill, www.unc.edu/depts/spice/chemical.html.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.